Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Illumina
ILMN
|
$779M |
| 2 |
QuantumScape
QS
|
$754M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$535M |
| 4 |
Booking.com
BKNG
|
$399M |
| 5 |
L3Harris
LHX
|
$322M |
Top Sells
| 1 |
DNKN
Dunkin' Brands Group, Inc.
DNKN
|
$476M |
| 2 |
Intuitive Surgical
ISRG
|
$469M |
| 3 |
Home Depot
HD
|
$454M |
| 4 |
Intel
INTC
|
$359M |
| 5 |
Salesforce
CRM
|
$350M |
Sector Composition
| 1 | Technology | 31.01% |
| 2 | Healthcare | 19.61% |
| 3 | Consumer Discretionary | 11.32% |
| 4 | Financials | 9.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SIVB
176
DELISTED
SVB Financial Group
SIVB
| $269M | 0.13% |
693,552
+2,439
| +0.4% | +$946K |
|
177
ResMed
RMD
$40.6B
| $266M | 0.12% |
1,250,324
-227,367
| -15% | -$48.3M |
|
178
Motorola Solutions
MSI
$79.8B
| $264M | 0.12% |
1,554,204
-501,523
| -24% | -$85.3M |
|
179
Amicus Therapeutics
FOLD
$2.46B
| $260M | 0.12% |
11,247,208
-2,859,051
| -20% | -$66M |
|
180
Caesars Entertainment
CZR
$5.48B
| $259M | 0.12% |
3,493,807
+17,919
| +0.5% | +$1.33M |
|
181
Kraft Heinz
KHC
$32.3B
| $259M | 0.12% |
7,465,330
+1,163,431
| +18% | +$40.3M |
|
|
182
Intel
INTC
$107B
| $259M | 0.12% |
5,190,645
-7,196,361
| -58% | -$359M |
|
|
GBT
183
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $258M | 0.12% |
5,966,862
+540,580
| +10% | +$23.4M |
|
|
RP
184
DELISTED
RealPage, Inc.
RP
| $258M | 0.12% |
2,953,709
-441,484
| -13% | -$38.5M |
|
|
MRTX
185
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $253M | 0.12% |
1,152,569
-726,211
| -39% | -$160M |
|
186
Tesla
TSLA
$1.13T
| $253M | 0.12% |
1,073,886
-418,221
| -28% | -$98.4M |
|
187
Take-Two Interactive
TTWO
$44.2B
| $252M | 0.12% |
1,213,710
-187,431
| -13% | -$38.9M |
|
188
Charles Schwab
SCHW
$167B
| $252M | 0.12% |
4,752,556
+4,227,648
| +805% | +$224M |
|
189
Gildan
GIL
$8.27B
| $248M | 0.12% |
8,851,743
+34,354
| +0.4% | +$962K |
|
190
CVS Health
CVS
$93.6B
| $248M | 0.12% |
3,627,691
+355,650
| +11% | +$24.3M |
|
191
Marsh & McLennan
MMC
$100B
| $246M | 0.11% |
2,106,689
+73,442
| +4% | +$8.59M |
|
192
Royalty Pharma
RPRX
$15.6B
| $245M | 0.11% |
4,901,700
+177,056
| +4% | +$8.86M |
|
193
Charter Communications
CHTR
$35.7B
| $242M | 0.11% |
366,390
+115,782
| +46% | +$76.6M |
|
194
T Rowe Price
TROW
$23.8B
| $236M | 0.11% |
1,561,519
+730,695
| +88% | +$111M |
|
195
Mercado Libre
MELI
$123B
| $236M | 0.11% |
140,599
+65,266
| +87% | +$109M |
|
|
XLRN
196
DELISTED
Acceleron Pharma Inc.
XLRN
| $232M | 0.11% |
1,814,041
+30,102
| +2% | +$3.85M |
|
197
Fate Therapeutics
FATE
$116M
| $231M | 0.11% |
2,545,568
-621,141
| -20% | -$56.5M |
|
|
VAR
198
DELISTED
Varian Medical Systems, Inc.
VAR
| $230M | 0.11% |
1,316,142
-48,553
| -4% | -$8.5M |
|
199
Analog Devices
ADI
$122B
| $230M | 0.11% |
1,555,967
-236,344
| -13% | -$34.9M |
|
200
Alibaba
BABA
$323B
| $230M | 0.11% |
987,093
-401,023
| -29% | -$93.3M |
|